Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON34072Active, not recruiting
Trial of gabapentin, remifentanil and diazepam in Neuralgia (3 arms), sponsored by Lygature. Primary endpoints: Area of secondary hyperalgesia, Area of tactile allodynia and 4 more. Started Jun 2010; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON34072.